Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis
- PMID: 18575623
- PMCID: PMC2430537
- DOI: 10.1371/journal.pone.0002468
Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis
Abstract
Introduction: The ability to preserve organs prior to transplant is essential to the organ allocation process.
Objective: The purpose of this study is to describe the functional relationship between cold-ischemia time (CIT) and primary nonfunction (PNF), patient and graft survival in liver transplant.
Methods: To identify relevant articles Medline, EMBASE and the Cochrane database, including the non-English literature identified in these databases, was searched from 1966 to April 2008. Two independent reviewers screened and extracted the data. CIT was analyzed both as a continuous variable and stratified by clinically relevant intervals. Nondichotomous variables were weighted by sample size. Percent variables were weighted by the inverse of the binomial variance.
Results: Twenty-six studies met criteria. Functionally, PNF% = -6.678281+0.9134701*CIT Mean+0.1250879*(CIT Mean-9.89535)2-0.0067663*(CIT Mean-9.89535)3, r2 = .625, , p<.0001. Mean patient survival: 93% (1 month), 88% (3 months), 83% (6 months) and 83% (12 months). Mean graft survival: 85.9% (1 month), 80.5% (3 months), 78.1% (6 months) and 76.8% (12 months). Maximum patient and graft survival occurred with CITs between 7.5-12.5 hrs at each survival interval. PNF was also significantly correlated with ICU time, % first time grafts and % immunologic mismatches.
Conclusion: The results of this work imply that CIT may be the most important pre-transplant information needed in the decision to accept an organ.
Conflict of interest statement
Figures
2−0.0067663*(CIT Mean−9.89535)
3. r2 = .625. p = <.0001.
References
-
- Pedotti P, Cardillo M, Rigotti P, Gerunda G, Merenda R, et al. A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation. 2004;77:1540–1545. - PubMed
-
- Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, et al. Risk factors for primary dysfunction after liver transplantation–a multivariate analysis. Transplantation. 1993;55:807–813. - PubMed
-
- Ploeg RJ, D'Alessandro AM, Hoffmann RM, Eckhoff D, Isaacs R, et al. Impact of donor factors and preservation on function and survival after liver transplantation. Transplantation Proceedings. 1993;25:3031–3033. - PubMed
-
- Brooks B, Levy M, Jennings L, Abbasoglu O, Vodapally M, et al. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation. 1996;62:1784–1787. - PubMed
-
- Cacciarelli TV, Dvorchik I, Mazariegos GV, Gerber D, Jain AB, et al. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1999;68:650–655. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
